The mainstay for the diagnosis for hepatocellular carcinoma (HCC) includes serological
tumor markers, such as-fetoprotein, the L3 fraction thereof and PIVKA-II, in addition to …

Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide, representing
also the main cause of death among cirrhotic patients. In contrast to most other solid tumors …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths
worldwide. If diagnosed early, curative treatment options such as surgical resection, loco …

Background: The effectiveness of tumor markers in evaluating outcomes of patients with
hepatocellular carcinoma (HCC) remains to be clarified. Summary: The usefulness of the …

Introduction: Current methods for HCC diagnosis have not an optimal diagnostic accuracy.
The detection of more than one biomarker seems to improve their individual performance …

Hepatocellular carcinoma (HCC) is a significant cause of mortality in patients with chronic
liver disease around the world. Development of biomarkers for early HCC detection is a …

Tumor biomarkers are important in the early screening, diagnosis, therapeutic evaluation,
recurrence and prognosis prediction of tumors. Primary liver cancer is one of the most …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death worldwide,
with region specific etiologies. Despite improvements made in the diagnosis of HCC, the …

The hepatocellular carcinoma (HCC) is one of the most common malignant tumors and
carries a poor survival rate. The management of patients at risk for developing HCC remains …

International Liver Cancer Association (ILCA) White Paper on Biomarker Development for
Hepatocellular Carcinoma Page 1 1 International Liver Cancer Association (ILCA) White Paper …